Halofantrine-associated ventricular fibrillation in a young woman with no predisposing QTc prolongation.
Gundersen
S G
SG
Department of Infectious Diseases, Ullevaal Hospital, University of Oslo, Norway.
Rostrup
M
M
von der Lippe
E
E
Platou
E S
ES
Myrvang
B
B
Edwards
G
G
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D010616:Phenanthrenes / Q000009:adverse effects* / Q000097:blood; D014693:Ventricular Fibrillation / Q000139:chemically induced*
D000962:Antimalarials; D010616:Phenanthrenes; C044961:1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol; C023768:halofantrine